ORIGINAL RESEARCH article
Front. Surg.
Sec. Visceral Surgery
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1630416
This article is part of the Research TopicAdvancing Benign Surgery: Techniques, Outcomes, and Educational InnovationsView all 7 articles
Impact of Bile Duct Stenting on the Management of Symptomatic Choledocholithiasis: A Retrospective Multicenter Analysis
Provisionally accepted
- 1University Hospital in Halle, Halle, Germany
- 2Department of Operative Medicine, Carl-von-Basedow-Hospital Saalekreis, Merseburg, Halle (Saale), Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Choledocholithiasis (CDL) can lead to various complications and requires treatment approaches for both biliary tract clearing and cholecystectomy. This study aims to characterize CDL patients, evaluate treatment strategies, assess associated complications, and explore economic impacts.Methods: We conducted a retrospective analysis of 112 patients between 2016 and 2021 at two centers.We performed a descriptive analysis comparing outcomes of patients undergoing ERCP with and without bile duct stenting. Univariate and multivariable analyses were used to identify factors related to complications.Results: Bile duct stenting was associated with significantly higher complication rates (52.4%) compared to the group without stenting (26.5%) (p=0.006). Factors influencing stent implantation included prior abdominal surgeries (OR = 3.51, p = 0.02), cholangitis at admission (OR = 3.02, p = 0.032), and bile duct diameter (OR = 1.16, p = 0.057). The overall median length of stay was longer for patients with stenting (19 days) compared to those without (11 days) (p<0.001). Finally, reimbursements were higher for patients with stenting. Reimbursement for complicated courses was higher than for those without, independent of initial bile duct stenting (with stent p=0.006, without stent p=0,003).Conclusion: Bile duct stenting during CDL management is associated with higher complication rates, longer hospital stay, and increased costs. These associations may reflect both clinical severity at baseline and procedural sequencing. A more restrictive placement of biliary stents might be advisable.
Keywords: Surgery, ERCP, Cholecysititis, Cholecystectomy, stent
Received: 17 May 2025; Accepted: 10 Jul 2025.
Copyright: © 2025 Rebelo, Tischer, Rosendahl, Walldorf, Mosa, Kleeff and Klose. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Artur Rebelo, University Hospital in Halle, Halle, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.